Crystal Colone, PA
Payments from drug & device makers
Across 666 payments — averaging $25.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$2K
- Alkermes, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- plus $6K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 59 | $2,034 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 66 | $1,881 |
| AbbVie | 91 | $1,843 |
| Alkermes, Inc. | 46 | $1,791 |
| Teva Pharmaceuticals USA, Inc. | 81 | $1,728 |
| Otsuka America Pharmaceutical, Inc. | 57 | $1,575 |
| Vanda Pharmaceuticals Inc. | 60 | $1,246 |
| Neurocrine Biosciences, Inc. | 33 | $1,164 |
| Novo Nordisk | 33 | $836 |
| Lundbeck LLC | 36 | $660 |
| E.r. Squibb & Sons, L.L.C. | 23 | $644 |
| Ironshore Pharmaceuticals Inc. | 20 | $506 |
| Sunovion Pharmaceuticals Inc. | 20 | $281 |
| Axsome Therapeutics, Inc. | 7 | $244 |
| Supernus Pharmaceuticals, Inc. | 4 | $178 |
| Indivior Inc. | 7 | $172 |
| Almatica Pharma LLC | 5 | $105 |
| OWP Pharmaceuticals, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $59 |
| Luye Pharma (USA) Ltd. | 2 | $48 |
| Adlon Therapeutics L.p. | 2 | $39 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Eisai Inc. | 2 | $33 |
| Noven Therapeutics, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Tris Pharma Inc | 1 | $14 |
How this compares
$17,238 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Norco
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.